GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » COGS-to-Revenue

Fractyl Health (Fractyl Health) COGS-to-Revenue : 0.58 (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health COGS-to-Revenue?

Fractyl Health's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.02 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.03 Mil.

Fractyl Health's COGS to Revenue for the three months ended in Mar. 2024 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fractyl Health's Gross Margin % for the three months ended in Mar. 2024 was 42.42%.

Fractyl Health COGS-to-Revenue Historical Data

The historical data trend for Fractyl Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health COGS-to-Revenue Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- - - - 0.64

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.65 0.69 0.29 0.58

Fractyl Health COGS-to-Revenue Calculation

Fractyl Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.077 / 0.12
=0.64

Fractyl Health's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.019 / 0.033
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fractyl Health  (NAS:GUTS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fractyl Health's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.019 / 0.033
=42.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Fractyl Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fractyl Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fractyl Health (Fractyl Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » COGS-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Website
https://www.fractyl.com
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.